A Randomised Phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients.
Primary Sponsor
NCIC Clinical Trials Group (NCIC CTG)
Related Post
24 February, 2026
First patient recruited for trial of new imaging modality for lung cancer
LATEST NEWS: 24 February 2026 The first Australian participant
